We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Diagnostic Test Uses Light to Detect Malaria without Blood Samples

By LabMedica International staff writers
Posted on 09 Jan 2023

Rapid tests, which are easy to deploy and require minimal equipment, provide an important diagnostic tool in the ongoing effort against malaria, which affects more than 250 million people around the world annually. More...

While the advent of these tests has greatly advanced diagnosis in regions where the disease is endemic, they still involve invasive blood draws from patients, which require skilled medical personnel and pose additional safety risks. Now, a team of scientists is developing an alternative: a rapid diagnostic test that uses light to diagnose the often deadly disease - no blood draws or finger pricks needed.

Current rapid malaria tests involve applying a blood sample to a testing strip that can detect the presence of malaria-causing plasmodium parasites in red blood cells. Such tests can be administered at the point of care and provide results in about 20 minutes, but also are inadequate for detection of asymptomatic infections where the level of parasites in blood is low. The team of scientists led by Johns Hopkins University (Baltimore, MD, USA) has improved on that model through the development of a hand-held screening device that can scan a patient’s arm or finger to detect the presence of malaria, eliminating the need to draw blood. Called ParaSpy Plus, the technology depends on an optical fiber probe that combines two spectroscopy modalities, label-free Raman spectroscopy and diffuse reflectance spectroscopy, or DRS, to noninvasively quantify malaria parasites in red blood cells.

Thanks to the fiber probe, Raman and DRS measurements are sequentially performed in vivo without sampling blood. When collected by the device, the measurements will then directly feed into artificial intelligence algorithms that can provide a quick and accurate diagnosis. The team plans to integrate its new sensing technology and AI software into a single portable screening device. And without any blood draws or sample preparation, the device can be used to screen for malaria outside of a clinical setting, such as in schools or community centers. The team expects that at the end of the three-year project period, the prototype will be ready for large-scale validation via clinical studies in different malaria-endemic regions. ParaSpy Plus will also be adaptable to the diagnosis and treatment of many other diseases, according to the team.

“With our proposed method, there are no invasive finger-pricks. Instead, we are working on a way to diagnose whether a person has malaria through non-invasive measurements using near-infrared light,” said team leader Ishan Barman, an associate professor of mechanical engineering in the Whiting School of Engineering. “The secondary goal of our work is to explore the capability of this platform for the diagnosis of diseases with high prevalence among the same populations, such as anemia and sickle cell disease.”

Related Links:
Johns Hopkins University 


Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.